Waypoint Bio: Series ADevelops AI-designed CAR T therapies for solid tumors using spatial biologyOct 4, 2026RoundOSWaypoint BioCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedAISeries A · AIBiotechUnited StatesEnterprise softwareNorth AmericaSeries A